Cargando…

Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa

MexAB-OprM and MexEF-OprN are Pseudomonas aeruginosa efflux pumps involved in the development of antibiotic resistance. Several studies developed with laboratory strains or using a few clinical isolates have reported that the regulation system of MexEF-OprN is involved in the final levels of MexAB-O...

Descripción completa

Detalles Bibliográficos
Autores principales: Horna, Gertrudis, López, María, Guerra, Humberto, Saénz, Yolanda, Ruiz, Joaquim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220265/
https://www.ncbi.nlm.nih.gov/pubmed/30405166
http://dx.doi.org/10.1038/s41598-018-34694-z
_version_ 1783368790856171520
author Horna, Gertrudis
López, María
Guerra, Humberto
Saénz, Yolanda
Ruiz, Joaquim
author_facet Horna, Gertrudis
López, María
Guerra, Humberto
Saénz, Yolanda
Ruiz, Joaquim
author_sort Horna, Gertrudis
collection PubMed
description MexAB-OprM and MexEF-OprN are Pseudomonas aeruginosa efflux pumps involved in the development of antibiotic resistance. Several studies developed with laboratory strains or using a few clinical isolates have reported that the regulation system of MexEF-OprN is involved in the final levels of MexAB-OprM expression. Therefore, this study was aimed to determine the interplay between MexAB-OprM and MexEF-OprN in 90 out of 190 P. aeruginosa clinical isolates with an efflux pump overexpression phenotype. Regarding oprD, 33% (30/90) of isolates displayed relevant modifications (RM) defined as frameshift or premature stop, both related to carbapenem resistance. On the other hand, 33% of the isolates displayed RM in nalC, nalD or mexR, which were significantly associated with multidrug resistance (MDR), non-susceptibility to carbapenems, OprD alterations and strong biofilm production. Meanwhile, the RM in MexS were associated with presence of pigment (p = 0.004). Otherwise, when all the regulators were analysed together, the association between RM in MexAB-OprM regulators and MDR was only significant (p = 0.039) when mexS was the wild type. These data show the modulatory effect of MexEF-OprN on MexAB-OprM in a clinical population of P. aeruginosa. Further studies may contribute to design of novel molecules acting on this interplay to fight against antimicrobial resistance.
format Online
Article
Text
id pubmed-6220265
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-62202652018-11-08 Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa Horna, Gertrudis López, María Guerra, Humberto Saénz, Yolanda Ruiz, Joaquim Sci Rep Article MexAB-OprM and MexEF-OprN are Pseudomonas aeruginosa efflux pumps involved in the development of antibiotic resistance. Several studies developed with laboratory strains or using a few clinical isolates have reported that the regulation system of MexEF-OprN is involved in the final levels of MexAB-OprM expression. Therefore, this study was aimed to determine the interplay between MexAB-OprM and MexEF-OprN in 90 out of 190 P. aeruginosa clinical isolates with an efflux pump overexpression phenotype. Regarding oprD, 33% (30/90) of isolates displayed relevant modifications (RM) defined as frameshift or premature stop, both related to carbapenem resistance. On the other hand, 33% of the isolates displayed RM in nalC, nalD or mexR, which were significantly associated with multidrug resistance (MDR), non-susceptibility to carbapenems, OprD alterations and strong biofilm production. Meanwhile, the RM in MexS were associated with presence of pigment (p = 0.004). Otherwise, when all the regulators were analysed together, the association between RM in MexAB-OprM regulators and MDR was only significant (p = 0.039) when mexS was the wild type. These data show the modulatory effect of MexEF-OprN on MexAB-OprM in a clinical population of P. aeruginosa. Further studies may contribute to design of novel molecules acting on this interplay to fight against antimicrobial resistance. Nature Publishing Group UK 2018-11-07 /pmc/articles/PMC6220265/ /pubmed/30405166 http://dx.doi.org/10.1038/s41598-018-34694-z Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Horna, Gertrudis
López, María
Guerra, Humberto
Saénz, Yolanda
Ruiz, Joaquim
Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
title Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
title_full Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
title_fullStr Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
title_full_unstemmed Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
title_short Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
title_sort interplay between mexab-oprm and mexef-oprn in clinical isolates of pseudomonas aeruginosa
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220265/
https://www.ncbi.nlm.nih.gov/pubmed/30405166
http://dx.doi.org/10.1038/s41598-018-34694-z
work_keys_str_mv AT hornagertrudis interplaybetweenmexaboprmandmexefoprninclinicalisolatesofpseudomonasaeruginosa
AT lopezmaria interplaybetweenmexaboprmandmexefoprninclinicalisolatesofpseudomonasaeruginosa
AT guerrahumberto interplaybetweenmexaboprmandmexefoprninclinicalisolatesofpseudomonasaeruginosa
AT saenzyolanda interplaybetweenmexaboprmandmexefoprninclinicalisolatesofpseudomonasaeruginosa
AT ruizjoaquim interplaybetweenmexaboprmandmexefoprninclinicalisolatesofpseudomonasaeruginosa